1[1]Gueritter VF, Guenard D, Lavelle F, et al. Relationships between the structure of toxal analongues and their antimitotic activity[J]. J Med Chem,1991,34:992
2[2]Nobholtz JM,Senn HJ, Bezwoda WR,et al.Prospective ran-domized trial of dovetarel versus mitomycin plus Vinblastine in patients with metastatic breast cancer progressing despite previous anthracy dinecontaining chemotherapy 304 study Group[J]. Chin Oncol, 1999 17,(15): 1413
3HENDERSON C, BERRY D A, DEMETRI G D, et al. Improved outcome from adding sequential paclitaxel but not from escalating doxorubicin does in an adjuvant chemotherapy regimen for patients with node-positive primary breatst cancer[J]. Clin Oncol , 2003,21:976-983.
